ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
Broker Notes
Top broker gives its verdict on the ResMed (ASX:RMD) share price
Share Market News
ASX 200 rises, Betmakers soars, REA Group drops
Share Fallers
Why BHP, Northern Star, REA, & ResMed shares are dropping
Share Market News
ASX 200 midday update: REA & ResMed results, Afterpay jumps
Healthcare Shares
Why the ResMed (ASX:RMD) share price slumped even as profit jumped
Ask a Fund Manager
How owning too much Afterpay (ASX:APT) was our biggest regret
Earnings Results
ResMed (ASX:RMD) share price on watch after beating expectations in FY21
Share Market News
5 things to watch on the ASX 200 on Friday
Ask a Fund Manager
These 2 hot ASX shares take up 20% of our fund: manager
Healthcare Shares
New Resmed (ASX:RMD) product could shake up market share – Expert
52-Week Highs
These ASX 200 shares have just hit 52-week highs
Ask a Fund Manager
Plumbing, health, tech: 3 ASX shares to buy for instant diversification
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
